Assessing medication adherence: options to consider A Lehmann, P Aslani, R Ahmed, J Celio, A Gauchet, P Bedouch, ... International journal of clinical pharmacy 36, 55-69, 2014 | 377 | 2014 |
Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions M Burnier, MP Schneider, A Chioléro, CLF Stubi, HR Brunner Journal of hypertension 19 (2), 335-341, 2001 | 345 | 2001 |
Evaluation of nurses' errors associated in the preparation and administration of medication in a pediatric intensive care unit. MP Schneider, J Cotting, A Pannatier Pharmacy World and Science 20, 178-182, 1998 | 164 | 1998 |
Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies J Marquis, MP Schneider, V Payot, AC Cordonier, O Bugnon, ... International journal of clinical pharmacy 35, 1130-1136, 2013 | 133 | 2013 |
An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring I Krummenacher, M Cavassini, O Bugnon, MP Schneider AIDS care 23 (5), 550-561, 2011 | 94 | 2011 |
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality TR Glass, JAC Sterne, MP Schneider, S De Geest, D Nicca, H Furrer, ... Aids 29 (16), 2195-2200, 2015 | 82 | 2015 |
Pharmacist-nurse collaborations in medication adherence-enhancing interventions: A review J Celio, F Ninane, O Bugnon, MP Schneider Patient education and counseling 101 (7), 1175-1192, 2018 | 76 | 2018 |
Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring V Santschi, G Wuerzner, MP Schneider, O Bugnon, M Burnier European journal of clinical pharmacology 63, 1179-1184, 2007 | 56 | 2007 |
Successful efavirenz dose reduction guided by therapeutic drug monitoring AF Mello, T Buclin, LA Decosterd, C Delhumeau, J di Iulio, A Fleurent, ... Antiviral therapy 16 (2), 189-197, 2011 | 55 | 2011 |
Interdisciplinary medication adherence program: the example of a university community pharmacy in Switzerland M Lelubre, S Kamal, N Genre, J Celio, S Gorgerat, D Hugentobler Hampai, ... BioMed research international 2015, 2015 | 50 | 2015 |
The presence of human immunodeficiency virus-associated neurocognitive disorders is associated with a lower adherence to combined antiretroviral treatment S Kamal, I Locatelli, G Wandeler, A Sehhat, O Bugnon, M Metral, ... Open forum infectious diseases 4 (2), ofx070, 2017 | 45 | 2017 |
Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study J Marquis, MP Schneider, B Spencer, O Bugnon, S Du Pasquier International journal of clinical pharmacy 36, 1014-1022, 2014 | 45 | 2014 |
Adherence: a review of education, research, practice and policy in Switzerland MP Schneider, I Krummenacher, H Figueiredo, J Marquis, O Bugnon Pharmacy practice 7 (2), 63, 2009 | 34 | 2009 |
Motivational interviewing to support medication adherence in adults with chronic conditions: systematic review of randomized controlled trials M Papus, AL Dima, M Viprey, AM Schott, MP Schneider, T Novais Patient Education and Counseling 105 (11), 3186-3203, 2022 | 32 | 2022 |
Adhésion thérapeutiquedu MP Schneider, L Herzig, D Hugentobler, O Bugnon Rev Med Suisse 9, 1032-6, 2013 | 31 | 2013 |
Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study I Krummenacher, M Cavassini, O Bugnon, R Spirig, MP Schneider, ... Pharmacy world & science 32, 776-786, 2010 | 31 | 2010 |
Patterns of adherence to raltegravir-based regimens and the risk of virological failure among HIV-infected patients: the RALTECAPS cohort study G Gras, MP Schneider, M Cavassini, F Lucht, M Loilier, R Verdon, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 61 (3), 265-269, 2012 | 30 | 2012 |
Forgiveness of dolutegravir-based triple therapy compared with older antiretroviral regimens: a prospective multicenter cohort of adherence patterns and HIV-RNA replication JJ Parienti, AL Fournier, L Cotte, MP Schneider, M Etienne, G Unal, ... Open Forum Infectious Diseases 8 (7), ofab316, 2021 | 29 | 2021 |
Effect of adherence on pharmacokinetic/pharmacodynamic relationships of oral targeted anticancer drugs E Cardoso, C Csajka, MP Schneider, N Widmer Clinical pharmacokinetics 57 (1), 1-6, 2018 | 29 | 2018 |
Therapeutic drug monitoring of targeted anticancer protein kinase inhibitors in routine clinical use: a critical review E Cardoso, M Guidi, B Blanchet, MP Schneider, LA Decosterd, T Buclin, ... Therapeutic drug monitoring 42 (1), 33-44, 2020 | 28 | 2020 |